Bicyclic aryl and heteroaryl receptor modulators

Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S336000, C514S357000, C514S619000

Reexamination Certificate

active

08063247

ABSTRACT:
Compounds of formula (I) or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful inter alia for the treatment of obesity.

REFERENCES:
patent: 6028175 (2000-02-01), Grandy et al.
patent: 6225080 (2001-05-01), Uhl et al.
patent: 2006/0217372 (2006-09-01), Blanco-Pillado et al.
patent: 2010/0113512 (2010-05-01), Ignar
patent: 2010/0173886 (2010-07-01), Bloxham et al.
patent: 0843726 (1998-05-01), None
patent: WO-9507983 (1995-03-01), None
patent: WO-9707212 (1997-02-01), None
patent: WO-03101963 (2003-12-01), None
patent: 2004026305 (2004-04-01), None
patent: WO-2004080968 (2004-09-01), None
patent: WO-2004080996 (2004-09-01), None
patent: WO-2005061442 (2005-07-01), None
patent: WO-2005066164 (2005-07-01), None
patent: WO-2005090286 (2005-09-01), None
patent: WO-2005090303 (2005-09-01), None
patent: WO-2005090337 (2005-09-01), None
patent: WO-2005092836 (2005-10-01), None
patent: WO-2007047397 (2007-04-01), None
patent: 2008021849 (2008-02-01), None
patent: WO-2008021851 (2008-02-01), None
patent: WO-2008032156 (2008-03-01), None
patent: 2008059335 (2008-05-01), None
International Search Report in PCT/GB2008/050801.
International Preliminary Report on Patentability and Written Opinion of the International Searching Authority in PCT/GB2008/050801.
Diaz et al., “SAR and biological evaluation of noveltrans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists.”Bioorg. Med. Chem. Lett., 15:3844-3848 (2005).
Takeuchi et al., “Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 2”,Bioorg. Med. Chem. Lett., 17:6841-6846 (2007).
Takeuchi et al., “Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part I”,Bioorg. Med. Chem. Lett., 17:5349-5352 (2007).
Zhang et al., “The μ-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist”,Eur. J. Pharmacol., 545:147-152 (2006).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Bicyclic aryl and heteroaryl receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic aryl and heteroaryl receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic aryl and heteroaryl receptor modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4272089

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.